The Trans-Led Care Study

NARecruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Substance AbuseSubstance AddictionSubstance Use Disorder (SUD)Substance Use (Drugs, Alcohol)Human Immunodeficiency Virus (HIV)
Interventions
BEHAVIORAL

The TLC Program

Participants randomized to the TLC Program will receive TAU plus the telehealth, peer-delivered group intervention. The TLC Program was adapted from Acceptance and Commitment Therapy (ACT) - an acceptance and mindfulness-based third wave cognitive behavioral therapy. The intervention will be delivered in a group format with peer facilitators via telehealth using videoconferencing. The protocol covers all six ACT core concepts (i.e., contact with the present, acceptance, defusion, self-as-context, values, and committed action) with tailored examples and exercises focused on gender affirmation, internalized stigma, and substance use. Additional sessions are included defining stigma, how stigma affects physical and sexual health and engagement with healthcare, and values-driven self-care goals of substance use reduction and healthcare engagement. Sessions are approximately 1.5 hours each and are delivered over 12 weeks.

Trial Locations (1)

60616

RECRUITING

Illinois Institute of Technology, Chicago

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Illinois Institute of Technology

OTHER